Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

43
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
43
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 慢性腎臓病のリスクのある人における様々な血清クレアチニン検査頻度による診断結果

慢性腎臓病のリスクのある人における様々な血清クレアチニン検査頻度による診断結果

Marcello Tonelli1, Natasha Wiebe2, Ronald T Gansevoort3

  • 1Department of Medicine, University of Calgary.

Journal of the American Society of Nephrology : JASN
|September 3, 2025

関連する実験動画

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

40.0K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

17.8K
A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
07:07

A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice

Published on: May 10, 2013

43.6K

PubMed で要約を見る

まとめ
この要約は機械生成です。

年齢やリスク因子に基づいて血清クレアチニン検査の頻度を調整することで,慢性腎臓病 (CKD) を検出するために必要な検査の数を大幅に減らすことができます. このアプローチは診断の成果を最大化し 医療資源を節約します

科学分野:

  • 腎臓科
  • 公衆衛生
  • 臨床診断

背景:

  • 現在のガイドラインでは,慢性腎臓病 (CKD) のスクリーニングのために,糖尿病または高血圧の患者に定期的に血清クレアチニン検査を行うことを推奨しています.
  • しかし,この検査の最適な頻度は未定です.
  • この研究では,発生性CKDの検査頻度の変化による診断結果が調査されています.

研究 の 目的:

  • 慢性腎臓病 (CKD) の診断率を年次検査と比べて異なる検査頻度 (2,3,4年,または5年) に基づいて決定する.
  • 年齢,性別,併発症,アルブミヌリア,CKDリスクスコアが血清クレアチニン検査の診断結果にどのように影響するかを評価する.

主な方法:

  • カナダのアルバータ州で3,515,163人の成人を対象に,人口ベースで遡及的なコホート研究が行われ,最初の推定グルメルフィルタレーション率 (eGFR) は60mL/ min/ 1. 73m2以上であった.
  • この研究では,様々な試験間隔で発生したCKDの診断率 (≥2のeGFR測定値<60mL/min/1. 73m2) を評価した.
  • 分析は,人口統計的要因と臨床的リスク指標によって分層化されました.

主要な成果:

  • 年1回の新規CKD症例を検出するために必要な検査数は,高齢者 (> 70歳) と比較して,若者 (< 50歳) で大幅に高かった.

関連する実験動画

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

40.0K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

17.8K
A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
07:07

A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice

Published on: May 10, 2013

43.6K
  • 検査頻度は,糖尿病,高血圧,心不全の患者でより高い確率で,異なるリスクグループにおける診断結果に著しく影響した.
  • 糖尿病や高血圧患者の検査頻度を 3年ごとに減らせば 診断を遅らせますが 毎年何百万人もの検査を回避できます
  • 結論:

    • 血清クレアチニン検査の頻度は,患者の年齢および他のCKDリスク因子の存在に基づいて個別化されるべきである.
    • テストの間隔を調整することで,不必要な実験室の利用を削減しながら,発生したCKDの検出を最適化できます.
    • このパーソナライズされたアプローチは 診断の効率を高め 医療費を削減する可能性があります